generic drug approvals

Biosimilar of Remicade Launched
Biosimilar of Remicade LaunchedRenflexis has wholesale cost 35% below Remicade.
How Drug Companies use Loopholes  to Delay Generic Drug Approvals
How Drug Companies use Loopholes to Delay Generic Drug ApprovalsThe citizens petition process is being used to delay approval of generic drugs.
Expedited FDA approval plays dominant role in drug approvalsLast year was a banner year for generic drug approvals by the FDA. Find out what’s in store for 2017.
FDA generics backlog improves, although criticism continuesWhile many groups are criticizing the FDA backlog of generic drug approvals, the agency has released the numbers on approvals and tentative approvals for 2015.